The Development of Cannabinoid CBII Receptor Agonists for the Treatment of Central Neuropathies

E-ISSN： 1875-6166|10|1|47-64

ISSN： 1871-5249

Source： Central Nervous System Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Central Nervous System Agents), Vol.10, Iss.1, 2010-03, pp. : 47-64

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cannabinoid receptor agonists and antagonists

By Barth F.

Expert Opinion on Therapeutic Patents, Vol. 8, Iss. 3, 1998-03 ,pp. : 301-313

Informa Healthcare

Access to resources Recommend Favorite

Cannabinoid CB1 and CB2 Receptor Ligand Specificity and the Development of CB2-Selective Agonists

Current Medicinal Chemistry, Vol. 15, Iss. 14, 2008-06 ,pp. : 1428-1443

Bentham Science Publishers

Access to resources Recommend Favorite

Therapeutic potential of cannabinoid receptor agonists as analgesic agents

By Fox Alyson Bevan Stuart

Expert Opinion on Investigational Drugs, Vol. 14, Iss. 6, 2005-06 ,pp. : 695-703

Informa Healthcare

Access to resources Recommend Favorite

Latest advances in cannabinoid receptor antagonists and inverse agonists

By Muccioli Giulio G Lambert Didier M

Expert Opinion on Therapeutic Patents, Vol. 16, Iss. 10, 2006-10 ,pp. : 1405-1423

Informa Healthcare

Access to resources Recommend Favorite

Recent advances in cannabinoid receptor agonists and antagonists

By Goya P. Jagerovic N.

Expert Opinion on Therapeutic Patents, Vol. 10, Iss. 10, 2000-10 ,pp. : 1529-1538

Informa Healthcare

Access to resources Recommend Favorite